| __timestamp | Regeneron Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 18516000 |
| Thursday, January 1, 2015 | 1620577000 | 34140000 |
| Friday, January 1, 2016 | 2052295000 | 51872000 |
| Sunday, January 1, 2017 | 2075142000 | 71772000 |
| Monday, January 1, 2018 | 2186100000 | 97501000 |
| Tuesday, January 1, 2019 | 3036600000 | 118590000 |
| Wednesday, January 1, 2020 | 2735000000 | 169802000 |
| Friday, January 1, 2021 | 2908100000 | 192507000 |
| Saturday, January 1, 2022 | 3592500000 | 199563000 |
| Sunday, January 1, 2023 | 4439000000 | 253598000 |
| Monday, January 1, 2024 | 5132000000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Xencor, Inc. have demonstrated contrasting approaches to research and development (R&D) spending. Regeneron, a leader in the field, has consistently invested heavily in R&D, with expenditures growing by approximately 250% from 2014 to 2023. In 2023 alone, Regeneron allocated nearly 4.4 billion dollars to innovation, underscoring its commitment to groundbreaking therapies.
Conversely, Xencor, a smaller player, has shown a more modest increase in R&D spending, with a growth of around 1,270% over the same period. Despite its smaller scale, Xencor's strategic investments have enabled it to carve out a niche in antibody and protein engineering. This comparison highlights the diverse strategies within the biotech industry, where both giants and emerging companies strive to push the boundaries of medical science.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Xencor, Inc.
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Novavax, Inc.
Regeneron Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
R&D Insights: How GSK plc and Xencor, Inc. Allocate Funds
Insmed Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Veracyte, Inc. vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: ACADIA Pharmaceuticals Inc. vs Xencor, Inc.
R&D Spending Showdown: Protagonist Therapeutics, Inc. vs Xencor, Inc.